Bandhan Nifty100 Low Volatility 30 Index Fund
The scheme seeks to replicate the Nifty100 Low Volatility 30 index by investing in securities of the Nifty100 Low Volatility 30 Index in the same proportion / weightage with an aim to provide returns before expenses that closely correspond to the total return of Nifty100 Low Volatility 30 Index, subject to tracking errors.
Growthvine rating: 3/5 — ranked #65 of 245 in category.
Fund basics
| Category | Equity: Index |
|---|
| NAV | ₹14.29 (as of 2026-10-22) |
|---|
| AUM | ₹1,604 Cr |
|---|
| Expense ratio | 0.79% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Abhishek Jain |
|---|
| Exit load | 0 |
|---|
Performance & risk
| Sharpe ratio | 0.19 |
|---|
| Standard deviation | 15.08% |
|---|
| Max drawdown | −18.48% |
|---|
| Alpha | -1.06 |
|---|
| Beta | 0.88 |
|---|
Market cap allocation
| Large cap | 96.8% |
|---|
| Mid cap | 3.2% |
|---|
| Small cap | 0.0% |
|---|
Concentration
| Top 5 holdings | 19.0% |
|---|
| Top 10 holdings | 36.9% |
|---|
| Total holdings | 30 |
|---|
Top holdings
- ICICI Bank Ltd. — 3.8%
- Sun Pharmaceutical Industries Ltd. — 3.8%
- Apollo Hospitals Enterprises Ltd. — 3.8%
- NTPC Limited — 3.8%
- Britannia Industries Ltd. — 3.7%
- Bharti Airtel Ltd. — 3.7%
- Kotak Mahindra Bank Ltd. — 3.6%
- SBI Life Insurance Company Limited — 3.6%
- Nestle India Ltd. — 3.5%
- ITC Ltd — 3.5%
Top sectors
- Banking & Financial — 13.9%
- Pharma & Biotech — 13.8%
- Energy — 10.6%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −11.7% | — | — |
| 2025 | 10.2% | — | — |
| 2024 | 10.8% | — | — |
| 2023 | 29.6% | — | — |